Innovative research and development is the cornerstone of Fosun Wanbang Pharma Group’s core competitiveness!
Fosun Wanbang Pharma Group invests 5% -10% of its annual operating income for drug research and development,
Nearly 300 full-time R&D technicians,
World-class R&D and production bases of prokaryotic and eukaryotic genetically engineered drugs.